Akihiro Nishiyama
5PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Oct 25, 2024
Pembrolizumab efficacy in a tumor mutation burden-high glioblastoma patient: A case study and implications for precision oncology.Akihiro Nishiyama, Shigeki Sato, Hiroyuki Sakaguchi
|Sep 28, 2022
High levels of AXL expression in untreated EGFR-mutated non-small cell lung cancer negatively impacts the use of osimertinib.Akihiro Yoshimura, Tadaaki Yamada, Masakuni Serizawa
|Apr 01, 2022
Inhibition of EGFR and MEK surmounts entrectinib resistance in a brain metastasis model of NTRK1-rearranged tumor cells.Chiaki Suzuki, Akihiro Nishiyama, Sachiko Arai
|Jun 19, 2021
Trametinib overcomes KRAS-G12V-induced osimertinib resistance in a leptomeningeal carcinomatosis model of EGFR-mutant lung cancer.Koji Fukuda, Sakiko Otani, Shinji Takeuchi
|Aug 01, 2020
MET amplification results in heterogeneous responses to osimertinib in EGFR-mutant lung cancer treated with erlotinib.Akihiro Nishiyama, Shinji Takeuchi, Yuta Adachi
Pageof 1
Frequent Collaborators
4 joint publications
Seiji Yano
2 joint publications
Koji Fukuda
2 joint publications
Atsushi Tajima
2 joint publications
Hiroshi Kotani
2 joint publications
Shinji Takeuchi
1 joint publications
Koichi Goto
1 joint publications
Chiaki Suzuki
1 joint publications
Shoichiro Tange
1 joint publications
Akihiro Yoshimura
1 joint publications
Tadaaki Yamada
